Skip to main content
OpenTrials

Clinical trial condition

Non-Squamous Non-Small Cell Lung Cancer

Explore clinical trials studying Non-Squamous Non-Small Cell Lung Cancer. Study availability and eligibility vary by location and protocol.

69 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Non-Squamous Non-Small Cell Lung Cancer trial results

Completed

An Observational Study of Tarceva (Erlotinib) in Participants With Locally Advanced or Metastatic Adenocarcinoma Non-Small Cell Lung Cancer (ELEMENT)

NCT01836133

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Clinical Center of Serbia; Institute For Pulmology Belgrade, Serbia
  • Institute for Oncology and Radiology of Serbia; Medical Oncology Belgrade, Serbia
  • Military Medical Academy; Clinic for Pulmonology Belgrade, Serbia
  • Institute for pulmonary diseases of Vojvodina Kamenitz, Serbia
View Trial Details
Completed

Study of Paclitaxel/Carboplatin With or Without Bavituximab in Previously Untreated Non Small-Cell Lung Cancer

NCT01160601

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Ironwood Cancer and Research Center Chandler, Arizona, United States
  • Baptist Clinical Research Jonesboro, Arkansas, United States
  • American Institute of Research Whittier, California, United States
  • Baptist Cancer Institute Jacksonville, Florida, United States
View all 40 locations
View Trial Details
Completed

A Study of Onartuzumab in Combination With Erlotinib in Patients With MET-Positive Stage IIIB or IV Non-Small Cell Lung Cancer Carrying an Activating Epidermal Growth Factor Receptor (EGFR) Mutation

NCT01887886

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Bakersfield, California, United States
  • Fullerton, California, United States
  • Long Beach, California, United States
  • Los Angeles, California, United States
View all 35 locations
View Trial Details
Completed

A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung)

NCT01456325

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Chandler, Arizona, United States
  • Hayward, California, United States
  • Modesto, California, United States
  • Oakland, California, United States
View all 213 locations
View Trial Details
Completed

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

NCT01366131

Conditions
Non-Squamous Non-Small Cell Lung Cancer
Locations
  • Birmingham, Alabama, United States
  • Hot Springs, Arkansas, United States
  • Santa Monica, California, United States
  • Orlando, Florida, United States
View all 42 locations
View Trial Details

Related conditions